| Name | Title | Contact Details |
|---|
BPM+ Health™ is a community initiative to improve the quality and consistency of healthcare delivery. It will achieve this by applying business process modeling standards to clinical best practices, care pathways and workflows directly at the point of care. It is a cross-discipline group of professional organizations, clinical societies, and healthcare providers working together to develop and pilot standards-driven healthcare process automation techniques to fully realize the benefits of Healthcare IT. Founding Members: American College of Emergency Physicians (ACEP), Auxilium Technology Group, EvidenceCare, Mayo Clinic, MDIX, Perspecta, Red Hat, Trisotech, University of Utah, University of Washington, U.S. Department of Veterans Affairs Industry Supporters: HIMSS, HL7, HSPC, NCQA, AHRQ BPM+ Health is a program of the Object Management Group® (OMG®).
3LAB Inc is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Crozer-Keystone Health System is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Crozer-Keystone Health System is based in Chester, PA. You can find more information on Crozer-Keystone Health System at www.crozer.org
New London Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. New London Hospital is based in New London, NH. You can find more information on New London Hospital at www.newlondonhospital.org
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.